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Abstract Apoptosis plays an important role in neurodegenera-
tion, although the mechanisms and mediators in the brain are
largely unknown. Because microglial cells have been suggested to
contribute to apoptosis in neurological disorders, we investigated
the expression of the death ligand CD95L in this cell type. We
found that, compared to classical mediators of microglial
activation, the most potent inducer of CD95L was oxidative
stress. Exposure of microglial cells to H2O2 or paraquat rapidly
triggered CD95L mRNA and protein expression, associated with
the activation of transcription factor NF-UB. Enhanced expres-
sion of CD95L was further found following exposure of cells to
hypoxia and subsequent reoxygenation. Our results indicate a
potential role of CD95L in oxidative stress-mediated cell death,
ischemia/reperfusion and other diseases with a disturbed redox
balance.
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1. Introduction
CD95 (APO-1/Fas) belongs to the tumor necrosis factor
(TNF) receptor superfamily whose members have a wide
range of functions related to cell survival, di¡erentiation
and regulation of the immune response. It was the ¢rst recep-
tor whose role seemed to be largely restricted to induction of
apoptosis. Upon crosslinking by agonistic antibodies or its
cognate ligand, CD95 mediates apoptosis in sensitive target
cells of di¡erent origin [1]. The ligand CD95L is a type II
transmembrane protein of 40^42 kDa which, after cleavage
by a metalloprotease, can also occur as a soluble form. Ex-
pression of CD95L has been mainly detected in activated T
lymphocytes, although other cell types such as NK cells,
monocytes and a number of non-lymphoid cells can also ex-
press this cytokine. Recently, it has been demonstrated that
CD95L-induced apoptosis involves the activation of death
proteases of the caspase family [1]. Ligation of CD95 triggers
its association with the cytoplasmic adapter protein FADD
through homophilic interaction with the so-called death do-
main. This event in turn recruits caspase-8 which is assumed
to cleave and activate other caspases and death substrates.
The function of the CD95 system has mainly been inves-
tigated in the immune system, but it is becoming evident that
CD95 also plays a role in other tissues. Naturally occurring
mouse strains, which lack expression of either functional
CD95 or its ligand, exhibit severe autoimmune disorders, in-
dicating a major role for CD95 in regulation of the immune
response and maintenance of self-tolerance. Whereas CD95-
mediated apoptosis is mainly controlled by inducible CD95L
expression, some cells constitutively express the ligand. High
amounts of CD95L are detected, for instance, in Sertoli cells
of the testis and epithelial cells of the anterior eye chamber
[2,3]. This led to the proposal that CD95 accounts for main-
taining the immune privilege of these organs by preventing
activated lymphocytes from tissue in¢ltration. Constitutive
expression of CD95L has further been found in tumor cells
of di¡erent origin, suggesting that similar mechanisms may
allow tumor cells to escape the host’s immune surveillance [1].
Recent studies provided evidence that CD95 participates in
a number of diverse apoptosis settings. Thus, CD95 was sug-
gested to play a role in cell death induced upon viral infection,
such as HIV-1-induced T lymphocyte apoptosis and HBV-
induced death of hepatocytes [4,5]. In addition, apoptosis
evoked by di¡erent physiochemical stresses including the ex-
posure of cells to anti-tumor drugs or irradiation, may be at
least partially mediated by the CD95 system [6^8]. It has been
observed that in these cases cellular stress leads to the up-
regulation of CD95L expression, which then upon binding
to its receptor induces cell death.
Important mediators of di¡erent physical and chemical
stresses comprise reactive oxygen intermediates (ROIs) includ-
ing hydroxyl radical, superoxide anion and H2O2. Although
ROI-mediated damage has been commonly considered as ne-
crosis, recent observations suggest a potential role of apopto-
sis under these conditions. Thus, excessive formation of ROIs
as well as the depletion of cellular antioxidants resulted in
apoptosis in di¡erent cell types [9^11]. Furthermore, a variety
of antioxidant compounds as well as the overexpression of
antioxidant enzymes inhibited cell death induced by apoptotic
agents [9]. However, although ROIs may be important, they
do not exert a common and obligatory role in all forms of
apoptosis. CD95-mediated apoptosis, for instance, is not or
only weakly diminished by treatment of cells with antioxi-
dants [12].
ROIs have been intimately implicated in the pathogenesis of
di¡erent neurodegenerative diseases [13^15]. Biochemical and
morphological alterations suggested that neuronal damage
during cerebral ischemia proceeds, at least partially, by apop-
tosis [16^18]. Ischemia/reperfusion of brain is usually associ-
ated with increased ROI formation and loss of endogenous
antioxidants [19]. It is therefore likely that ROIs either di-
rectly or indirectly contribute to neuronal damage. An indi-
rect e¡ect may be exerted by ROI-induced novel gene expres-
sion. In this respect, ROIs can activate redox-sensitive
transcription factors, such as NF-UB and AP-1, which may
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control the expression of death genes [20]. Supportive for the
requirement of de novo gene expression is the observation
that inhibitors of RNA and protein synthesis markedly at-
tenuate neuronal damage produced by ischemia/reperfusion
[21,22]. The mechanism of ischemic neuronal damage and
the genes involved, however, are unknown.
It is well established that microglia, which exert a primary
role as brain-resident macrophages, are involved in in£amma-
tory and destructive processes [23]. During ischemia/reperfu-
sion, activation of microglia coincides with the onset of DNA
degradation in regions of selective neuronal loss, thus suggest-
ing a possible role in neuronal cell death [24]. It is known that
activated microglia can produce several neurotoxins, such as
ROIs, nitric oxide, glutamate, cytokines or proteases which
could contribute to neuronal cell death [24^26].
Very little information exists about the function of CD95
and its ligand in physiological and pathological processes in
the brain. In view of increasing evidence for participation of
microglia in neurological disorders, we here investigated the
expression and regulation of CD95L in microglial cells. Our
experiments revealed that reagents inducing oxidative stress
were among the most potent activators of CD95L expression.
We further found that hypoxia followed by transient reoxy-
genation strongly upregulated CD95L expression. These ¢nd-
ings suggest that CD95L may potentially contribute to ROI-
mediated damage of neuronal or other cell types in diseases
characterized by an imbalance of redox homeostasis.
2. Materials and methods
2.1. Cell culture and reagents
N9 mouse microglial cells were grown in RPMI-1640 medium sup-
plemented with 10% FCS and 2 mM glutamine, and passaged by
trypsinization. Similar to primary microglia, cells express the pheno-
typic markers F4/80, Mac-1, FcR, and are able to produce IL-1K, IL-
6, and TNF [27,28]. The reagents paraquat, menadione, doxorubicin
and H2O2 as well as lipopolysaccharide (LPS) were purchased from
Sigma (Deisenhofen, Germany). TNF and GM-CSF were obtained
from Knoll AG (Ludwigshafen, Germany) and Genzyme (Cambridge,
MA, USA), respectively. For hypoxia experiments, cells were sub-
jected to mild controlled hypoxia in an atmosphere of 200 ppm oxy-
gen, a condition that does not inhibit respiration and normal adeny-
late energy charge [29]. Cells were placed at 37‡C in a sealed metal
chamber, which was £ushed with a water-saturated gas mixture of
0.02% O2, 5% CO2 and the balance made up by high purity argon
gas. The pH of the medium remained constant throughout the experi-
ments. A Clark-type electrode was placed into a medium-¢lled culture
dish to determine the actual oxygen pressure during the experiments.
To reoxygenate hypoxic cultures, cells were transferred into 1/4 vol-
ume of medium saturated with 95% O2 and 5% CO2. In order to
avoid artifacts after treatment, cell culture dishes were quickly re-
moved and the cells were immediately lysed in extraction bu¡er as
described below.
2.2. Detection of NF-UB DNA binding
Cells were plated at 1U106/well in six-well plates and treated for
45 min with the indicated concentrations of H2O2. Total cell extracts
for electrophoretic mobility shift assays (EMSAs) were prepared es-
sentially as described [30]. Equal amounts of the extracts (about 10 Wg
crude protein) were incubated with the 32P-labeled NF-UB-speci¢c
oligonucleotide. After 15 min binding reaction at room temperature,
samples were loaded on a 4% non-denaturing polyacrylamide gel. The
oligonucleotide with a high-a⁄nity NF-UB binding motif (Promega,
Heidelberg, Germany) was labeled using Q-[32P]-ATP (3000 Ci/mmol;
Amersham-Buchler, Braunschweig, Germany) and T4 polynucleotide
kinase (Boehringer, Mannheim, Germany).
2.3. Detection of CD95L mRNA expression by RT-PCR
Expression of CD95L mRNA was examined by reverse transcrip-
tion (RT)-PCR. Total cellular RNA was extracted from 1U106 N9
cells by the acidic guanidinium thiocyanate phenol-chloroform meth-
od. One Wg of total RNA was reverse transcribed after heat denatu-
ration (3 min, 60‡C) and annealing with 2.5 WM random hexamer
primers (Perkin Elmer, Weiterstadt, Germany) in the presence of 50
U MnLV RT (Perkin Elmer), 5 mM MgCl2 and 1 mM of each dNTP
in 20 Wl for 30 min at 42‡C. The reaction was stopped by heat in-
activation for 5 min at 95‡C. Aliquots of 10 Wl of the cDNA were then
ampli¢ed in a DNA thermocycler (Stratagene, Heidelberg, Germany)
with 1.25 U of Ampli-Taq DNA-polymerase (Perkin Elmer), 100 pM
of both upstream and downstream CD95L primers and 2 mM MgCl2
in a volume of 50 Wl. Each of the PCR cycles consisted of a denatu-
ration step (94‡C, 1 min), an annealing step (57‡C, 1 min) and an
elongation step (72‡C, 1 min). For histone H3.3 mRNA expression,
which was analyzed as a control for sample loading and integrity, 2 Wl
cDNA were ampli¢ed (1 min 94‡C, 1 min 60‡C, 1 min 72‡C). The
PCR products (836-bp mouse CD95L fragment, 522-bp H3 fragment)
were separated by electrophoresis on a 1.5% agarose gel and visual-
ized by ethidium bromide staining. Primers used for ampli¢cation
were mouse CD95L sense primer corresponding to nucleotides 179^
200 (5P-CCATGCAGCAGCCCATGAATTA-3P) and antisense pri-
mer complementary to nucleotides 1015^993 (5P-GCTTATA-
CAAGCCGAAAAAGGTC-3P), and H3 sense (nucleotides 40^59;
5P-ACTGGTGGTAAAGCACCCAG-3P) and antisense primer (nu-
cleotides 562^543; 5P-TGTCCCCTATTTTCCACTCG-3P).
2.4. Western blotting
Cells were seeded on 10-cm dishes at 2U106/dish and stimulated
with H2O2. After the indicated time, cells were washed in ice-cold PBS
and lysed for 10 min in 50 mM Tris-HCl pH 7.6 containing 1% NP-
40, 300 mM NaCl and protease inhibitors (3 Wg/ml leupeptin, 3 Wg/ml
aprotinin, 2 mM PMSF). Cellular proteins from 1U106 cells were
loaded in each lane and electrophoretically separated on a 10% poly-
acrylamide gel in the presence of SDS and reducing conditions. Fol-
lowing SDS-PAGE, proteins were transferred to nitrocellulose mem-
branes by semi-dry electroblotting. Membranes were blocked
overnight with 5% non-fat dry milk powder in PBS and then incu-
bated for 1 h with anti-CD95L (0.25 Wg/ml; Signal Transduction;
Dianova, Hamburg, Germany). Membranes were washed 3 times
with PBS/0.05% Tween-20 and incubated with peroxidase-conjugated
a⁄nity-puri¢ed rabbit anti-mouse IgG for 1 h. Following extensive
washing, the reaction was developed by enhanced chemiluminescent
staining using ECL reagents (Amersham-Buchler).
2.5. Immunocytochemical detection of CD95L
For indirect immuno£uorescence, cells were plated on Permanox
plastic chamber slides (Lab-tek, Nunc, Wiesbaden, Germany) at
1U104 cells/well and ¢xed after overnight incubation for 10 min
with a cold mixture of methanol and acetone (1:1). After rinsing in
PBS, slides were blocked for 30 min with 10% FCS and 1% H2O2 in
PBS. Incubation with anti-CD95L (2 Wg/ml) was performed for
30 min, followed by incubations for 30 min each with biotinylated
anti-mouse-IgG and streptavidin-peroxidase. Between each of these
steps, slides were intensively washed in PBS/0.05% Tween-20. The
specimens were then stained for 5 min with a Tyramide signal ampli-
¢cation kit (TSA NEL 701; DuPont NEN, Boston, MA, USA) and
mounted in Elvanol. Fluorescence microscopy was performed with a
Zeiss Axiovert microscope. Negative controls included omission of the
primary antibody, and the use of isotype-matched irrelevant antibody.
In addition, preadsorption experiments with recombinant CD95L
were performed.
3. Results and discussion
3.1. The pro-oxidants H2O2 and paraquat are strong inducers
of CD95L expression
We investigated the inducible expression of CD95L in
mouse N9 microglial cells, which exhibit several functional
characteristics of primary microglia [27]. In the initial experi-
ments, cells were stimulated with di¡erent inducers of micro-
glial activation, before mRNA was isolated, reverse-tran-
scribed and ampli¢ed by RT-PCR using CD95L-speci¢c
primers. As shown in Fig. 1, CD95L-speci¢c PCR products
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were barely detected in unstimulated cells. Treatment of cells
with H2O2 potently induced CD95L mRNA expression with-
out a¡ecting expression of the histone gene H3.3, which was
analyzed as a control for equal mRNA loading. Although to a
lesser extent, CD95L mRNA was also inducible by LPS and
TNF, which act as potent activators of microglial cells [23]. In
contrast, GM-CSF, a frequently used microglial mitogen, was
unable to increase CD95L-speci¢c transcripts. A potent acti-
vation was further observed following exposure of N9 cells to
paraquat, a compound increasing intracellular formation of
ROIs by redox cycling. The chemotherapeutic drugs doxoru-
bicin and menadione, however, were almost ine¡ective in in-
ducing CD95L expression. These results indicate that, in com-
parison to traditional stimuli of microglial activation such as
LPS, reagents generating oxidative stress including H2O2 and
paraquat are the most potent activators of CD95L expression
in microglial cells.
3.2. Time course and dose-dependency of H2O2-induced
CD95L mRNA expression
In order to investigate the kinetics of CD95L expression,
cells were stimulated with 250 WM H2O2 over di¡erent time
intervals, before CD95L mRNA expression was analyzed. As
shown in Fig. 2A, the time course of CD95L expression was
fast, and signi¢cant amounts of CD95L-speci¢c PCR prod-
ucts were already detected 1 h after stimulation. The kinetics
of CD95L expression in response to H2O2 was transient.
Maximal expression was obtained within 2^4 h and thereafter
declined. In addition, induction of CD95L mRNA was dose-
dependent (Fig. 2B). Strong expression was detected after a
4-h exposure to 250 WM H2O2, whereas lower as well as high-
er concentrations resulted in weaker induction levels.
3.3. CD95L mRNA expression is associated with increased
NF-UB DNA binding
The proximal 300-bp sequence upstream of the CD95L
gene contains several cis-regulatory binding sites for transcrip-
tion factors [31]. Although only a limited number of studies
have yet addressed their functional importance, the region at
nucleotides 3275 to 3264 (GGAAACTTCC) constitutes a
putative UB-binding motif. Because transcription factor NF-
UB is controlled by redox processes [20], we investigated the
activation of NF-UB DNA binding in response to H2O2 in
microglial cells. As shown in Fig. 2C, stimulation of cells with
di¡erent concentrations of H2O2 induced NF-UB activation in
a dose-response similar to CD95L as seen in the previous
experiments. Although these experiments do not prove a func-
tional role of NF-UB, together with previous reports [32,33],
the results indicate that NF-UB may be of importance in ox-
idative stress-induced CD95L expression.
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Fig. 2. A: Kinetics of CD95L mRNA expression in response to
H2O2. Total RNA of cells treated for the indicated times with 500
WM H2O2 was reverse-transcribed and analyzed for CD95L- and
H3-speci¢c ampli¢cation products. B: Dose-response of CD95L
mRNA expression. Cells were stimulated for 4 h in duplicates with
the indicated concentrations of H2O2 and analyzed for the presence
of RT-PCR speci¢c ampli¢cation products. C: The e¡ect of H2O2
on NF-UB activation. After treatment of cells for 45 min with the
indicated concentrations of H2O2, cell extracts were prepared and
analyzed by EMSA using a 32P-labeled NF-UB speci¢c oligonucleo-
tide. The position of the NF-UB-DNA complexes is indicated by ar-
rowheads. The speci¢city of the NF-UB DNA complex was veri¢ed
by supershift analyses with NF-UB speci¢c antibodies (data not
shown, see [28]).
Fig. 1. Induction of CD95L mRNA in microglial N9 cells. Cells
were either left untreated (Co) or stimulated with the following re-
agents: H2O2 (500 WM), LPS (100 ng/ml), TNF (50 ng/ml), GM-
CSF (50 ng/ml), doxorubicin (Doxo, 1 Wg/ml), paraquat (Para, 500
WM) or menadione (Men, 500 WM). After 4 h, RNA was isolated
and subjected to RT-PCR. The PCR products were separated on a
1.5% agarose gel and visualized by ethidium bromide staining. The
products of CD95L and H3 gene ampli¢cation migrated at the pre-
dicted size of 836 bp and 522 bp, respectively. A DNA size marker
(M) is shown on the left.
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3.4. E¡ects of H2O2 on CD95L protein expression
We next investigated whether H2O2 also increased the func-
tional expression of CD95L protein. N9 cells were stimulated
with 250 WM H2O2, and after di¡erent time points cell lysates
were prepared and subjected to Western blot analysis using
CD95L-speci¢c antibodies. CD95L protein, which was not
detectable in unstimulated cells, was increasingly expressed
following prolonged exposure to H2O2 (Fig. 3A). CD95L-spe-
ci¢c signals revealed a doublet protein band of approximately
40^42 kDa which corresponded to the published molecular
size and probably represented di¡erentially glycosylated forms
of CD95L. Fig. 3B demonstrates that CD95L expression was
dose-dependent. CD95L protein was most strongly expressed
after incubation with 1 mM H2O2.
The ability of H2O2 to induce CD95L protein expression
was veri¢ed by immuno£uorescence analysis. CD95L-speci¢c
signals were almost undetectable in unstimulated cells, where-
as stimulation with H2O2 produced an intensive cytoplasmic
and membrane staining in N9 cells (Fig. 3C). The staining
reaction was speci¢c for CD95L, since almost no £uorescent
signal was detected, when isotype-matched control antibodies
were used (Fig. 3C) or when the antibodies were preabsorbed
with recombinant CD95L (data not shown).
3.5. Exposure of microglia to hypoxia/reoxygenation induces
CD95L expression
An important pathophysiological correlate of H2O2 stimu-
lation is cerebral hypoxia/reperfusion, which results in in-
creased oxidative stress and subsequent neuronal damage
caused by apoptosis. It has been documented that microglia
may contribute to cell death associated with hypoxic/ischemic
injury [23]. To investigate the regulation of CD95L expression
in this context, we exposed N9 cells to mild hypoxic condi-
tions, which were not directly cytotoxic and did not inhibit
respiration or normal adenylate energy charge [29]. Cells were
cultivated in a tight incubation chamber under 200 ppm O2
over di¡erent time intervals, followed by a 1-h incubation
under normoxic conditions. As demonstrated in Fig. 4A,
this hypoxia/reoxygenation treatment resulted in increased ex-
pression of CD95L mRNA. Incubation of cells with pro-
longed times of hypoxia (up to 8 h) led to elevated CD95L
expression. In contrast, transcription of the house-keeping
gene H3 was not altered under these conditions. In another
experimental setting, cells were incubated under hypoxic at-
mosphere for 6 or 8 h, followed by di¡erent times of reoxy-
genation. These experiments revealed that a transient reoxy-
genation period of 1 h was su⁄cient and optimal to increase
CD95L expression, whereas longer normoxic incubations had
markedly weaker e¡ects (Fig. 4B). Corresponding to the pre-
vious experiment, a prolonged hypoxic incubation of 8 h was
superior to activate CD95L expression than a shorter period.
These data demonstrate that hypoxia/reoxygenation po-
tently induces expression of CD95L, which may thus be a
potential mediator of microglial-derived cytotoxic activity.
Several recent studies have emphasized a causative role of
ROIs in apoptosis of neurodegenerative diseases including
amyotrophic lateral sclerosis, Parkinson’s and Alzheimer’s
disease [13,14,34]. A critical role of ROI-mediated apoptosis
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Fig. 3. H2O2 increases CD95L protein expression. A: Time kinetics of inducible CD95L expression. N9 cells were incubated with 250 WM
H2O2. After the indicated time, cell lysates were prepared, electrophoresed on a 10% SDS-PAGE and transferred by Western blotting. CD95L
was detected with a CD95L-speci¢c antibody and visualized by enhanced chemiluminescent staining. The Western blot shows a CD95L-speci¢c
protein doublet band of 40^42 kDa. B: Dose response of CD95L expression. N9 cells were stimulated with the indicated concentrations of
H2O2. Cell lysates were prepared after 12 h. C: Immuo£uorescent detection of CD95L. Cells were either left untreated (A) or stimulated with
250 WM H2O2 (B,C). After 12 h, cells were ¢xed and incubated with an isotype-matched IgG1 control antibody (B) or with anti-CD95L (A,C),
and analyzed by £uorescent microscopy.
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has been proposed for ischemia/reperfusion injury, where clas-
sical morphological alterations of apoptosis can be demon-
strated [15]. It has been shown that the apoptosis-inhibitory
proteins of the Bcl-2 family as well as pharmacological inhib-
itors of caspases prevent hypoxic injury [11]. In addition, neu-
rons of Bcl-2 transgenic mice are highly resistant to ischemia
[35], suggesting that oxidative damage, although formerly re-
garded as necrosis, can be attributed to the activation of the
apoptotic programme.
Histological studies on transient ischemic insults in brain
demonstrated that certain neurons of the hippocampus are
particularly susceptible to ischemic apoptosis [16,18]. Cell
death of such neurons usually occurred after an interval of
1^2 days following reperfusion. This delay of cell death indi-
cates that apoptosis may be not a direct consequence of hy-
poxia-mediated e¡ects, but rather requires hypoxia-induced de
novo protein synthesis. Consistent with this assumption, a
considerable reduction of neuronal cell death in the hippo-
campus was achieved after injection of the protein synthesis
inhibitor cycloheximide [21,22]. Studies investigating the tem-
poral and spatial patterns of apoptosis in hypoxia-mediated
injury found that microglial activation coincided with the on-
set of DNA degradation in regions of selective neuronal loss,
suggesting a possible role of microglia in induction of apop-
tosis [23,24]. Although various small molecules that can trig-
ger apoptosis are known, the mechanisms and identity of
death proteins in this process are unclear.
In the present study, we show that oxidative stress induced
by H2O2 and paraquat is a strong inducer of CD95L expres-
sion in N9 microglial cells. Interestingly, pro-oxidant stimuli
were signi¢cantly stronger in inducing CD95L expression than
classical mediators of microglial activation, such as LPS or
TNF. Since ischemia/reperfusion represents an important
pathophysiological equivalent of oxidative stress, we further
investigated the e¡ects of hypoxia/reoxygenation on CD95L
expression. Similarly to the pro-oxidants, hypoxia and subse-
quent reoxygenation were found to be potent CD95L-induc-
ing conditions. The induction of CD95L was more pro-
nounced with increased periods of hypoxia and required
brief subsequent reoxygenation. This indicates that gene in-
duction was indeed dependent on pro-oxidative signaling and
not mediated by other potential side e¡ects of hypoxia. The
activation of CD95L by H2O2 corresponded to the increased
activation of NF-UB which contains a potential binding site in
the CD95L promoter [31]. Although the role of NF-UB in the
control of CD95L has not yet been fully established, recent
studies using speci¢c inhibitors of the transcription factor
pointed out that NF-UB may be involved in CD95L expres-
sion in T lymphocytes [32,33]. It is interesting to note that
high levels of active NF-UB have been detected in microglia of
neurodegenerative diseases [36].
Currently, there exists only a paucity of information about
the function of CD95 in the nervous system. Whereas CD95 is
weakly expressed in normal brain [37], upregulation of the
CD95 receptor has been detected in postischemic brain as
well as in brain tissues from Alzheimer’s and multiple sclerosis
patients [38^41]. Hence, these ¢ndings favor a role of the
CD95 system in causing or exacerbating neurodegenerative
diseases. However, it cannot be excluded that CD95L may,
oppositely, exert a protective e¡ect. Since brain is an estab-
lished immunoprivileged organ, it is possible that, similarly to
the eye and testis, CD95L is involved in maintaining the im-
munoprivilege of the nervous system. A recent study surpris-
ingly demonstrated that mutant mice lacking both TNF re-
ceptors are highly susceptible to neuronal damage associated
with cerebral ischemia [42]. Thus, TNF obviously plays an
unde¢ned protective role in these processes, although previous
studies have indicated a neurotoxic e¡ect of TNF under cer-
tain conditions. Therefore, until the relative neurotoxic or
protective roles of CD95 are not de¢ned, the consequences
of CD95L expression have to await further studies.
Hypoxia/reperfusion is an important cause of injury in a
variety of tissues other than brain which are highly susceptible
to a dysfunctional redox balance. Upregulation of CD95
mRNA has been reported following hypoxia in rat cardio-
myocytes [43], suggesting that under this condition CD95-
mediated apoptosis may be of functional importance. Our
¢ndings that CD95L gene transcription is highly inducible
by hypoxia/reperfusion and other forms of oxidative stress
may also be relevant for tumor-associated hypoxia. It is con-
ceivable that, in particular, those tumor cells growing in a
hypoxic environment may upregulate CD95L expression and
thereby establish an immunoprivileged state which allows tu-
mor cells to escape immunosurveillance. Another important
aspect may be chemotherapeutic drug-induced apoptosis of
tumor cells, which has been proposed to require at least par-
tially induction of CD95L expression [6,7]. Interestingly,
many drugs, such as anthraquinones, that undergo redox cy-
cling, continuously produce ROIs and activate NF-UB [44].
Collectively, oxidative signaling leading to CD95L expression
may presumably play a role in diverse apoptosis settings in-
volving the CD95 system.
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Fig. 4. E¡ect of hypoxia/reoxygenation on CD95L expression. A:
N9 cells were either left under normoxia (Co) or incubated for the
indicated time under mild hypoxia (Hyp, 200 ppm O2) followed by
a subsequent 1-h reoxygenation (Reox) period. Total RNA was har-
vested and ampli¢ed by RT-PCR as described in Fig. 1. M denotes
a DNA size standard. B: N9 cells were either left untreated or incu-
bated under hypoxia for 6 or 8 h. Following di¡erent incubation
times of reoxygenation, RNA was isolated and subjected to RT-
PCR using CD95L and H3-speci¢c primers.
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